Increased polyol pathway due to aldose reductase activation and advanced glycation endproducts (AGEs) formation have been implicated as an important molecular mechanism of how hyperglycemia causes diabetic complications.
1)Aldose reductase (alditol/NADP ϩ oxidoreductase, EC 1.1.1.21, ALR2) is the first enzyme of the polyol pathway which reduces excess D-glucose into D-sorbitol with concomitant conversion of NADPH to NADP ϩ , 2,3) which has been demonstrated to play important roles not only in the cataract formation in the lens 4) but also in the pathogenesis of diabetic complications such as neuropathy, 5) nephropathy 6) and retinopathy.
7)Prolonged hyperglycemia can also result in the formation of AGEs in body tissues. The complex, fluorescent AGE molecules formed during the Maillard reaction can lead to protein cross-linking and contribute to the development and progression of several diabetic complications such as cataract, atherosclerosis, nephropathy and neuropathy. 8) Since the discovery that ALR2 and AGEs may play an important role in pathogenesis of diabetic complications, several synthetic and naturally occurring compounds have been studied for their in vitro and in vivo activities. Several studies of naturally occurring flavonoids on the inhibition of ALR2 and AGEs, and their structure-activity relationship have been reported. [9][10][11] Increased oxidative stress is a widely accepted participant in the development and progression of diabetes and their complications. Diabetes is usually accompanied by an increased production of free radicals and/or impaired antioxidant defenses. 12,13) It would therefore seem desirable that ALR2 inhibitors possess AGEs inhibitory and antioxidative potencies.Rhus verniciflua grows particularly in South East Asia and the biological activities of this plant have been reported as anti-inflammatory, 14) anti-cancer, 15) and anti-rheumatoid arthritis, 16) etc.In the present study, we investigated the inhibitory effect of the bark of R. verniciflua on ALR2 and AGEs to evaluate its potential use for the treatment of diabetic complications. This investigation led to the isolation and identification of the compounds that inhibit the activity of ALR2 and AGEs. Furthermore, we investigated whether the active compound for ALR2 and AGEs was able to scavenge free radical using luminometry (Photochem ® ).
MATERIALS AND METHODSChemicals First grade solvents were used for extraction, fractionation and column chromatography. Kiesel gel 60 (70-230 mesh, Art, 7734 Merck) was used as the column packing material. Kiesel 60 F 254 (precoated plate, Art. 5559, Merck) was used for thin layer chromatography (TLC). Iodine vapor and 10% H 2 SO 4 were used for TLC detection. DLGlyceraldehyde, D-glucose, bovine serum albumin (BSA), DTT and NADPH were purchased from Sigma Chemical (St. Louis, MO, U.S.A.). Ampicillin, IPTG and imidazole were purchased from USB Corporation (Cleveland, OH, U.S.A.). Human ALR2 cDNA clone was purchased from 21C Frontier Human Gene Bank (Daejeon, Korea).Plant Materials The...